SAN DIEGO, April 3, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that it garnered news coverage on leading stock website The Motley Fool.
A Mar. 31, 2018, article on The Motley Fool’s website entitled “Say What? This GOP Senator Wants to Legalize Hemp” analyzes Mitch McConnell’s recent announcement of the Hemp Farming Act of 2018 and his previous legislative work that steered hemp into the 2014 Farm Bill.
The article states that “Should industrial hemp get the all-clear from the federal government, the only potential publicly traded winner looks to be Medical Marijuana Inc., which markets and distributes hemp oil-based products, as well as researches cannabinoid-based pharmaceuticals.”
Medical Marijuana, Inc. currently produces its full spectrum cannabidiol (CBD) hemp oil, Real Scientific Hemp Oil™, from industrial hemp grown in Europe. If made into law, the Hemp Farming Act of 2018 would not only generate a major market opportunity for U.S. farmers to potentially source CBD oil for such products from U.S.-based hemp crops, but it could make hemp cultivation legal federally as well.
The article continues stating, “Given that hemp contains considerably higher cannabidiol content relative to the cannabis plant — cannabidiol, or CBD, is the non-psychoactive component known for its medical benefits — paving the way for industrial hemp and continued research could allow Medical Marijuana Inc.’s business in the U.S. to build momentum.”
“We are thrilled that investors are recognizing how significant this yet-to-be-introduced bill would be for the Company,” said Medical Marijuana, Inc. CEO Dr. Titus. “If made into law, this new hemp legislation would give us exponential opportunities for growth and our flagship product, Real Scientific Hemp Oil, could become a more widespread standard for CBD hemp oil across the nation.”